(Q28286099)

English

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

hypertriglyceridemia

1 reference

based on heuristic

inferred from title

Michal Vrablík

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Richard Češka

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Philippa Talmud

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Jaroslav A Hubacek

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Wu-Wei Wang

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Zdena Skodová

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Vera Adámková

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

0 references

publication date

1 January 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

46

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

773-777

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Hypertriglyceridemia: interaction between APOE and APOAV variants.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.160

21 January 2018

Identifiers

10.1515/CCLM.2008.160

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18601597%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28286099&oldid=1505105609"